Not sure where to start? Get matched →
PE-22-28 (Injectable)
Cognitive

PE-22-28 (Injectable)

TREK-1 mood & neuro peptide

All-in monthly price

$219

No membership fee · this is the full price · free shipping · avg 4-week supply

Medication, provider care, labs & dose adjustments — all in one price.
~28-day supply. Your provider sets your exact dose, so yours may vary — your refill arrives as you finish the last one.
Start assessment

Add in-depth bloodwork

Optional — add a physician-reviewed at-home blood panel to your plan.

At-home kit (1 device)+$149

Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.

Money-back guarantee
Free AI care assistant
HSA/FSA accepted
Cancel anytime
Free shipping

This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Dr. Gene
Physician Reviewed

Reviewed by Dr. Gene, MD · Board-certified Family Medicine

Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.

About

PE-22-28 (Injectable)

A peptide fragment studied as a TREK-1 potassium channel activator, explored for mood support and neuroprotection. Compounded; not FDA-approved.

Benefits
Mood & stress support
Neuroprotection
TREK-1 channel activator
Rapid-acting research peptide
Supply per fill
28-day

About a 4-week supply supply at the standard prescribed dose — your physician confirms exact dosing.

Physician review
24 hrs

A licensed US physician reviews your intake and prescribes when appropriate.

FDA-registered pharmacy
503A

Compounded fresh at a US pharmacy and shipped cold-chain to your door.

Shipping, always
Free

Every order ships free — medication, physician care and refills, one all-in price.

Formulation
Injectable vial5 mL · 2 mg/mL
PE-22-2810 mg

Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.

Quality

Every batch independently tested

Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.

USP <71>
Sterility

Confirms the finished preparation is free of viable microorganisms.

USP <85>
Bacterial endotoxins

Screens for endotoxins that can cause fever or inflammatory reactions.

Assay
Potency

Verifies the labeled concentration of the active peptide is what is in the vial.

HPLC
Purity

Checks the active peptide against impurities and degradation products.

Mass spectrometry
Identity

Confirms the peptide in the vial is the correct molecule.

USP <791>
pH

Confirms the solution sits within the range specified for injection.

USP <788>
Particulate matter

Checks the finished vial for visible and sub-visible particles.

USP <1207>
Container closure integrity

Confirms the vial seal holds so sterility is maintained through the beyond-use date.

Recent lots
  • Lot 100526-PE-2

    Tested 2026-10-07 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    101.7%

  • Lot 092826-PE-2

    Tested 2026-09-30 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    100.9%

  • Lot 092126-PE-2

    Tested 2026-09-23 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    98.9%

Compounded by licensed U.S. pharmacies. Prescribed by licensed medical providers. Shipped directly to patients.Documentation available upon request →View lab results by lot →
Your protocol

How PE-22-28 is prescribed.

Who it's for
  • Adults with a low, flat mood their physician has evaluated
  • People under chronic stress who want support without a conventional antidepressant
  • Patients who understand the evidence is from animal studies
  • Anyone pairing it with Selank or Semax for mood and focus

Your physician decides whether PE-22-28 is appropriate for you after reviewing your intake and labs.

Directions & duration

Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday.

Cycle. One small injection each day, Monday through Friday. Ongoing monthly treatment; your physician adjusts the dose as your goals evolve.
Directions shown are the pharmacy's standard for this preparation. Your prescription label is the final word.
What's included
  • Licensed physician review of your intake, history, and labs
  • Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
  • Every batch independently tested before release
  • Sterile syringes and alcohol prep pads for injectables
  • Tracked delivery to your door, refills on schedule
  • Message your physician anytime; dose changes without an appointment
Storage & handling
  • Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
  • One vial is your monthly supply. A fresh vial ships every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
  • Protect from light. Wipe the stopper with an alcohol pad before every draw.
  • Dispose of syringes in the sharps container per the included instructions.
What to expect

A typical course of PE-22-28.

TimeframeWhat patients commonly report
Weeks 1–2A lift in mood and motivation is the earliest report; response varies.
Weeks 3–8A steadier mood and better stress tolerance are what patients report most in this window.
OngoingLong-term treatment. Refills ship every 28 days, and your physician adjusts the dose over time as your goals evolve.
Individual results vary. Compounded medications are not FDA-approved; a licensed physician determines whether treatment is appropriate and monitors your progress.
The full reference

Everything published
about PE-22-28.

How it is described to work, pathway by pathway. What the research shows and what it does not. Where it stands with the FDA, dated and sourced.

Read the reference
13
References

peer-reviewed, each verified on PubMed

14
Sections

mechanism, evidence, dosing, safety, FAQ

Sep 24
FDA status verified

2026 · checked against fda.gov, not memory

The science

How PE-22-28 works, and what the research shows.

How it works

PE-22-28 is a small piece of a natural brain protein that blocks a channel in nerve cells tied to mood.

Blocking it is studied for a fast lift in mood and for helping the brain grow new cells.

Clinical evidence
  • Rodent studies reported antidepressant-like effects within days and new brain-cell growth.

    Djillani and colleagues, 2017
  • There are no published controlled human trials.

Full references with PubMed links are listed further down the page.

References

  1. Djillani A, Pietri M, Moreno S et al.. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity · Front Pharmacol (2017) · PMID 28955242
  2. Mazella J, Pétrault O, Lucas G et al.. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design · PLoS Biol (2010) · PMID 20405001
  3. Heurteaux C, Lucas G, Guy N et al.. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype · Nat Neurosci (2006) · PMID 16906152
  4. Moha Ou Maati H, Veyssiere J, Labbal F et al.. Spadin as a new antidepressant: absence of TREK-1-related side effects · Neuropharmacology (2012) · PMID 21807005
  5. Devader C, Khayachi A, Veyssière J et al.. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin · Br J Pharmacol (2015) · PMID 25598009
  6. Moha ou Maati H, Bourcier-Lucas C, Veyssiere J et al.. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function · Brain Struct Funct (2016) · PMID 25233810
  7. Ye D, Li Y, Zhang X et al.. TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling · Eur Neuropsychopharmacol (2015) · PMID 26441141
  8. Hivelin C, Béraud-Dufour S, Devader C et al.. Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin · J Diabetes Res (2016) · PMID 28105440
  9. Devader C, Roulot M, Moréno S et al.. Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients · J Affect Disord (2017) · PMID 27838145
  10. Roulot M, Minelli A, Bortolomasi M et al.. Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients · Neuropsychiatr Dis Treat (2018) · PMID 30233189
  11. Qi X, Xu H, Wang L et al.. Comparison of Therapeutic Effects of TREK1 Blockers and Fluoxetine on Chronic Unpredicted Mild Stress Sensitive Rats · ACS Chem Neurosci (2018) · PMID 29952548
  12. Djillani A, Pietri M, Mazella J et al.. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin · Pharmacol Ther (2019) · PMID 30291907
  13. Pietri M, Djillani A, Mazella J et al.. First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides · Neuropharmacology (2019) · PMID 31325429

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Important safety information

+

Possible side effects

• Mild redness or swelling at injection site
• Temporary fatigue or headache
• Mild nausea (uncommon)

Do not use if you have

• Active cancer or history of cancer (unless approved by oncologist)
• Pregnancy or breastfeeding
• Severe kidney or liver disease
• Known allergy to the peptide or excipients

If you experience severe side effects, call 911 or go to your nearest emergency room.

How supplied

5 mL multi-dose vial, PE-22-28 2 mg/mL (10 mg PE-22-28 per vial)

Common questions

Frequently asked
about PE-22-28 (Injectable).

A peptide fragment studied as a TREK-1 potassium channel activator, explored for mood support and neuroprotection. Compounded; not FDA-approved. PE-22-28 is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

33 more questions about Pepti, answered.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Get started today

Ready to start with PE-22-28 (Injectable)?

Free assessment. Licensed physicians. Money-back guarantee if not approved.

Money-back guarantee
Free shipping
Cancel anytime
HSA/FSA accepted
Start free assessment
Total care.
In your pocket.

Message your medical team, track every order, chart every lab marker. 5.0 on the App Store.

Get the app
A hand holding an iPhone showing the Pepti app
Pharmacy network accreditation

PCAB-accredited pharmacies on every order.

Every fulfillment runs through a PCAB-accredited pharmacy.

See the lab results
PCAB — Pharmacy Compounding Accreditation Board · Accredited
  • Rigorous third-party quality & safety inspections
  • Cleanliness and sterile processes
  • Proper ingredient sourcing
  • Accurate dosing and formulation
  • Staff training and procedures
  • Accredited by NABP & ACHC